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Abstract
Background: VE-cadherin is an endothelial specific, transmembrane protein, that clusters at adherens junctions where it
promotes homotypic cell-cell adhesion. VE-cadherin null mutation in the mouse results in early fetal lethality due to altered
vascular development. However, the mechanism of action of VE-cadherin is complex and, in the mouse embryo, it is difficult
to define the specific steps of vascular development in which this protein is involved.
Methodology and Principal Findings: In order to study the role VE-cadherin in the development of the vascular system in a
more suitable model, we knocked down the expression of the coding gene in zebrafish. The novel findings reported here
are: 1) partial reduction of VE-cadherin expression using low doses of morpholinos causes vascular fragility, head
hemorrhages and increase in permeability; this has not been described before and suggests that the total amount of the
protein expressed is an important determinant of vascular stability; 2) concentrations of morpholinos which abrogate VE-
cadherin expression prevent vessels to establish successful reciprocal contacts and, as a consequence, vascular sprouting
activity is not inhibited. This likely explains the observed vascular hyper-sprouting and the presence of several small,
collapsing vessels; 3) the common cardinal vein lacks a correct connection with the endocardium leaving the heart
separated from the rest of the circulatory system. The lack of closure of the circulatory loop has never been described before
and may explain some downstream defects of the phenotype such as the lack of a correct vascular remodeling.
Conclusions and Significance: Our observations identify several steps of vascular development in which VE-cadherin plays
an essential role. While it does not appear to regulate vascular patterning it is implicated in vascular connection and
inhibition of sprouting activity. These processes require stable cell-cell junctions which are defective in absence of VE-
cadherin. Notably, also partial modifications in VE-cadherin expression prevent the formation of a stable vasculature. This
suggests that partial internalization or change of function of this protein may strongly affect vascular stability and
organization.
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Introduction
Homotypic endothelial cell-cell adhesion is particularly impor-
tant for the correct formation, networking and remodeling of
vessels. Endothelial cells are maintained in contact one another by
a complex network of transmembrane adhesion proteins anchored
to the actin cytoskeleton. Growing evidence indicates that
endothelial cell-cell adhesion is accompanied by intracellular
signaling which promotes the resting state of the cells and
contributes to their homeostasis [1–3]. It is well known that
cultured sparse and confluent cells present a different functional
phenotype. Gene expression profiles of sparse and confluent cells
also show that several genes are regulated by cell-cell contacts,
many of which are implicated in cell growth, apoptosis, matrix and
cytoskeletal remodeling [4–6].
Adherens and tight junctions (AJ and TJ respectively) are the
major adhesive junctions in endothelial cells. They are both
formed by transmembrane adhesive proteins that are linked inside
the cells to a complex network of cytoskeletal and signaling
partners [1,7–8]. Adhesion at AJs is induced by members of the
cadherin family. VE- and N-cadherin are the major cadherins
present in endothelial cells. However, only VE-cadherin is found
in the majority of inter-endothelial AJs both in vitro and in vivo.
Inactivation of VE-cadherin gene in mice leads to major defects in
vascular development causing embryo lethality around 9.5–10.5 E
[9,10]. While the first primitive vascular plexus is formed even in
the absence of VE-cadherin, the vessels are unable to further
progress and the vasculature undergoes regression. The mecha-
nism of action of VE-cadherin in vascular development is quite
complex. Several reports indicate that, besides its adhesive
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promote vascular stability and remodeling. Most of these activities,
however, have been studied in vitro in cultured cells and, due to the
early lethality of VE-cadherin null mouse embryos, it is difficult to
understand how and at which step of vascular development this
protein acts.
We therefore decided to use the zebrafish embryo which, due to
its transparency and external development, allows a more detailed
study of vascular defects [11–13]. Furthermore, only one VE-
cadherin orthologue has been identified in the fish that maintains
endothelial specific expression [14]. Our studies show that
reduction of VE-cadherin expression does not change vascular
patterning but leads to a concentration-dependent alteration in
vascular integrity and lumen formation. A novel finding derived
from the analysis of this phenotype is that the sprouting vessels lack
the capacity to establish successful reciprocal contacts and
subsequent fusion. When VE-cadherin expression is abrogated the
heart remains disconnected from the peripheral vascular network
and blood circulation is absent. When VE-cadherin expression is
only partially reduced, the vessels are fragile and hemorrhagic,
particularly in the head. These data support the notion that VE-
cadherin plays a non redundant role in maintaining the integrity of
endothelial cell-cell contacts and, as a consequence, in the
establishment of correctly interconnected vascular structures.
Notably, also partial modifications in VE-cadherin expression may
prevent the formation of a stable vasculature suggesting that also
small reduction in expression or function of this protein may
severely affect vascular integrity.
Materials and Methods
Zebrafish lines and husbandry
Zebrafish (Danio rerio) were raised and maintained as described
[15] in agreement with local and national sanitary regulations.
Wild type AB line and transgenic lines Tg(fli1:EGFP)
y1 and
Tg(flk1:EGFP)
s844 were used [16,17]. The transgenic line
Tg(fli1:EGFP)
y1 was used for general analysis of the vasculature.
The possibility to breed this line in homozygosis allows stronger
intensity of the fluorescent signal and better conditions for the
acquisition of long time-lapse series. However, cranial vessels
cannot be accurately imaged with the Tg(fli1:EGFP)
y1 line due to
the strong expression of EGFP in branchial arches, therefore, in
order to analyze the head vessels (cranial and aortic vessels), we
used the Tg(flk1:EGFP)
s844 line.
Embryo staging was performed according to morphology as
described [18].
Morpholino injections and RT-PCR
Two morpholino antisense oligonucleotides (Gene Tools) were
designed to complement exon-intron boundaries of the zebrafish
VE-cadherin/cdh5 gene (diagram in figure 1A; Ensembl accession
ENSDARG00000046128) in order to block splicing:
MO2 59-TACAAGACCGTCTACCTTTCCAATC-39;
MO3 59- ATTTGAGATGAACCTACCCAGGATG-39;
A 5 pb mismatch morpholino was used as control:
ctrlMO 59-TAgAAcACgGTCTAgCTTTCgAATC-39;
We used the morpholino against silentheart (sih)/tnnt2 gene, that
blocks translation of the thin-filament contractile protein cardiac
troponin T2, as previously described [19]. We injected 4 ng of
sihMO and confirmed the absence of the heart beat in sih
morphants by direct observation of the embryos under the
dissecting microscope at 26–30 hours postfertilization (hpf).
Morpholinos were reconstituted in nuclease-free water, and the
volume of the injected drop was estimated with a micrometer scale.
Embryos at 1- to 4-cell stage were injected with the indicated
amounts of morpholino into the yolk immediately below the
blastomeres. The efficacy of the morpholino was assessed by RT-
PCR with Superscript One-step RT-PCR system (Invitrogen) and
usingastemplatetotalRNAfromcontrolorVE-cadherinmorpholino
injected embryos. RNA was extracted with Trizol from 48 hpf
pooled embryos and treated with DNase. The primers used are:
VE5F 59-GATGAAACAGTGTGCCAGAAG-39;
VE3R 59-AGGCAGAAGACAGGATGGAGA-39;
e1F2 59-TGTATGCGTATGAGGAAACAC-39;
ActinF 59-ACCTCATGAAGATCCTGACC-39;
ActinR 59-TGCTAATCCACATCTGCTGG-39.
Microangiographies
Tetramethylrhodamine dextran (molecular weight 2610
6, Mo-
lecular Probes) was dissolved in PBS at 20 mg/ml and microin-
jected into the sinus venosus of anesthetized zebrafish embryos at
52–54 hpf. For embryos that exhibited no circulation, microinjec-
tion was performed directly into the heart chambers. Images of the
microangiograms were acquired within ten minutes upon injection.
Microscopy and confocal imaging
For imaging zebrafish vessels, live embryos were dechorionated
manually with forceps, anesthetized using 0.016% tricaine (Sigma)
and mounted in 1.2% low melting agarose. Image acquisition was
performed with 206or 406water immersion objective on a Leica
TCS SP2 confocal microscope. Confocal stacks were processed for
maximum intensity projections with Leica LCS software and
movies were assembled using ImageJ (MacBiophotonics).
For video recordings of heart beat and circulation, embryos
were anesthetized and mounted in 2% methylcellulose. Videos
were acquired under an Olympus SZX12 stereomicroscope
coupled with a JVC color video camera (Model TK-C148OBE)
using Pinnacle Studio Plus 9.3 software. Movies were compressed
with Quicktime.
Transplantation experiments (mosaic analysis)
Cell transplantations were performed as previously described
[15,20].Briefly,donorTg(fli1:EGFP)embryosweremicroinjectedat
1- to 4-cell stage with tetramethylrhodamine dextran (10,000 MW,
fluoro-ruby, Molecular Probes) and 8 ng of MO2for morphant into
AB wild type transplants. At sphere stage donor and host embryos
were dechorionated by a brief incubation with pronase (Sigma) and
transferred to agarose wells. About 20 cells were transplanted at the
margin of AB wild type host embryos and were incubated at 28.5uC
for further development. Chimeric embryos were analyzed under a
fluorescence stereoscope and images were aquired using a Nikon
Eclipse 90i fluorescence microscope.
TUNEL assay, immunocytochemistry and in situ
hybridization
Whole mount TUNEL assay was performed with Apoptag Red
In situ Apoptosis detection kit (Chemicon International). Immuno-
cytochemistry was performed as previously described [21]. Mouse
anti-human ZO-1 was clone ZO1-1A12 (Invitrogen). Whole-mount
in situ hybridization was performed as previously described [22].
Rescue experiments
A fusion construct containing murine VE-cadherin cDNA in
frame with mCherry [23] at the C-terminus was subcloned into
VE-Cadherin in Zebrafish
PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5772Figure 1. VE-cadherin morpholinos downregulate VE-cadherin expression in a dosage dependent manner. (A) Schematic representation
of zebrafish VE-cadherin/cdh5 gene with exons represented as black boxes. The positions of the morpholinos employed in this study are indicated
with red arrows, and the primers used for the analysis of splice variants as black arrows (VE5F, e1F2 and VE3R). (B–C) Expression of VE-cadherin was
analyzed by RT-PCR using two sets of primers. (B) Upon injection of high doses (16 ng) of VE-cadherin morpholinos, aberrant splicing of VE-cadherin
was observed for both MO2 and MO3 when using primer pair VE5F-VE3R. Primer pair e1F2-VE3R allowed the detection of endogenous wild type VE-
cadherin transcript in controls (Ctrl) and proved the absence of this transcript in MO2 injected embryos (left panel in B). This primer pair confirmed the
altered splicing for MO3 injected embryos (right panel in B). Actin was used as an internal control. (C) Injection of low doses of morpholino (0.8 ng)
caused partial knockdown of VE-cadherin. These embryos expressed both wild type VE-cadherin and aberrant spliced transcripts. (D–E) Histograms
show the quantification of the effect of VE-cadherin morpholinos at 54 hpf. Both MO2 (D) and MO3 (E) cause increased severity of the phenotype
increasing the doses injected. With low doses (0.8 ng) most of the embryos present circulation and hemorrhages (mild phenotype). Conversely,
injection of high doses of either one morpholino (16 ng) cause a highly penetrant phenotype, with complete absence of blood circulation (severe
phenotype). Intermediate amounts of morpholino lead to both mild and severe phenotype in different percentages. MO2 presented higher
penetrance than MO3.
doi:10.1371/journal.pone.0005772.g001
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promoter flanked by Tol2 transposable elements [24]. Coinjection
of 0.4 ng of MO2, 20 pg of plasmid DNA and 20 pg of Tol2
transposase mRNA [25] was performed directly into the
blastomere of 1-cell stage embryos. The phenotype of the injected
embryos was scored at 54 hpf. To evaluate the extent of mosaicism
we scored the average number of endothelial cells in a reference
area (see figure S2B) using tg(fli1:nEGFP)
y7 transgenic embryos
[20]. Then we scored the number of GFP-positive endothelial cells
in 40 embryos of the same age co-injected with 20 pg pTolfli-
EGFP (marking construct) and 20 pg pTolfli-mVE-cadherin:mCherry
(rescuing construct).
Results
Partial reduction of VE-cadherin expression affects
vascular integrity
To knock down VE-cadherin function in zebrafish we designed
morpholinos (modified antisense oligonucleotides) targeting either
exon 2-intron 2 boundary (MO2) or exon 11-intron 11 boundary
of the gene (MO3) (Figure 1A). Expression of VE-cadherin upon
morpholino injection was analyzed by RT-PCR using two sets of
primers. We used different doses of morpholinos to be able to
reduce VE-cadherin expression in a dose dependent manner. Upon
injection of a high dose (16 ng) of both morpholinos, aberrant
splicing of the VE-cadherin transcript was observed for MO2 and
MO3 by RT-PCR with primer pair VE5F-VE3R (Figure 1B).
Sequence analysis of the morphant transcripts confirmed that they
encoded truncated versions of VE-cadherin. Primer pair e1F2-
VE3R allowed the detection of endogenous wild type VE-cadherin
transcript in controls and proved the absence of this transcript in
MO2 injected embryos. In addition, this primer pair confirmed
the altered splicing for MO3 injected embryos (Figure 1B).
At a low dose (0.8 ng) of both morpholinos VE-cadherin
expression was partially knocked down but we could still detect
endogenous wild type VE-cadherin transcript in addition to the
alternatively spliced transcript (Figure 1C). At 30 hpf embryos
injected with low doses of VE-cadherin morpholinos appeared
morphologically normal (Movie S3) and essentially undistinguish-
able from ctrlMO injected embryo (Movie S1). They also
presented regular heart beat, comparable to that of control
embryos. However in 50% of these embryos, we could observe
blood cells blocked in cranial vessels (see pulsating cells in Movie
S3) impairing the correct completion of cranial circulatory loops.
Due to this, the number of circulating blood cells in the trunk was
reduced in these embryos (compare Movies S2 and S4).
Subsequently, by 52–54 hpf more than 60% of embryos injected
with low doses of either MO2 (0.4 ng, n=127) or MO3 (0.8 ng,
n=102) presented a hemorrhagic phenotype (Figure 1D,E and
figure 2B–D), not observed in control embryos (Figure 2A). The
hemorrhages were particularly frequent intracranially and/or at
the point of connection of aortic arches (AA) to the lateral dorsal
aorta (arrows and arrowheads in figure 2B–D). These embryos
were phenotypically classified as mild morphants. In 32% of the
cases the same embryo presented more than one hemorrhagic foci
(n=33/102). The intracranial hemorrhages were localized
randomly in forebrain, midbrain or hindbrain, and were equally
present on the right or the left side. MO2 caused more penetrant
alterations since at 0.8 ng, 80% of embryos showed hemorrhagic
Figure 2. Partial VE-cadherin knockdown causes vascular
instability and hemorrhages. (A–D) Bright field images of 52 hpf
embryos. Lateral views, anterior to the left. Embryos injected with low
doses (0.8 ng) of VE-cadherin morpholino (Low VEcadMO) develop
single (C) or multiple hemorrhages (B and D) that were evident at
52 hpf and appeared in the brain (arrows) and/or aortic arches
(arrowheads). No or very rare hemorrhages were observed in embryos
injected with mismatch control morpholino (ctrlMO) at the same
concentration (A). (E, F) Confocal images of Tg(flk1:EGFP) embryos at
54 hpf. Dorsal views, anterior to the left. In embryos injected with
ctrlMO (E), central arteries (CtA) extend from the basilar artery (BA)
towards forebrain and midbrain, and drain into the primordial hindbrain
channel (PHBC). In contrast, in Low VEcadMO injected embryos (F) only
few CtAs are formed, and those which are present fail to fuse to BA and
lack lumen (asterisks).
doi:10.1371/journal.pone.0005772.g002
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only 60% of morphants with hemorrhages (Figure 1D,E). By
further increasing the doses, more severe alterations of vascular
development were observed with both morpholinos. A higher dose
of MO3 was needed for causing fully penetrant severe phenotype
with complete absence of circulation (see below for full
description). We therefore selected MO2 for further studies.
In order to analyze in more detail the organization of the
vascular system, we used transgenic embryos expressing EGFP
under the flk1 promoter [17]. The dorsal view of the cranial
vasculature showed that in 54 hpf embryos injected with ctrlMO,
central arteries (CtAs) extended from the basilar artery (BA)
towards the forebrain and midbrain and drain into the primordial
hindbrain channel (PHBC) (Figure 2E). In contrast, embryos
injected with 0.8 ng of VE-cadherin morpholino (VEcadMO) that
developed hemorrhages presented marked alterations in vascular
development (Figure 2F). In embryos that had hemorrhages in the
midbrain, CtAs presented variable defects. On average two CtAs
per embryo were missing and two presented very small diameter,
lacked lumen and failed to fuse to the BA. These first observations
suggested that the overall perfusion of the head was compromised.
This was further confirmed by microangiographies performed at
52 hpf (Figure 3A–F). Embryos injected with ctrlMO have a
functional cranial vascular network with lumenized aortic arches
(AAs) and CtAs. Conversely, VEcadMO injected embryos lack
perfusion in the brain and present extravasation of the injected
dextran at the site of the hemorrhages (asterisks in figure 3B,C). In
addition, only aortic arch 1 (AA1) is fully formed in the morphants,
while AAs 3 through 6 do not exhibit circulation (Figure 3E,F).
Microangiographies were also performed to analyze the vessels of
the trunk in Tg(flk1:EGFP) embryos at 54 hpf. In control embryos
intersegmental vessels (ISVs), dorsal aorta (DA) and posterior
cardinal vein (PCV) are fully lumenized, the injected dextran is
confined to this primary vascular network and no leakage is
observed (Figure 3G–I). In VE-cadherin mild morphants these vessels
were apparently normal as detected by flk1:EGFP expression
(Figure 3J). However, in 30% of these morphants we observed
leakage of the fluorescent dye along the trunk vasculature in the
somitesandtissuesadjacenttotheISVs(arrowheadsinfigure3K,L).
Strong or complete reduction of VE-cadherin expression
impairs the development of a functional vascular
network
Embryos injected with 16 ng of VEcadMO present a normal
morphological development up to 30 hpf (Figure 4A,B). However
blood circulation is not established (Movie S6) despite the regular
heart beating (Movie S5), which indicates that the defect observed
is not of cardiac origin. At 48 hpf lack of circulation persists in the
morphants and is accompanied by pericardial edema (arrow in
figure 4D), not observed in control embryos (Figure 4C).
Microangiographies on flk1:EGFP transgenic embryos injected
with ctrlMO showed that the heart is interconnected with the AAs
which, at 52 hpf, show a correct lumen (Figure 4E,F). In contrast,
flk1:EGFP transgenic embryos injected with 16 ng of VEcadMO
form the endocardial layer inside the heart (En in figure 4G), but
connection with the AA1 and with the common cardinal vein
(CCV, also called Duct of Cuvier) is missing and microinjected
dextran is retained in the heart chambers (Figure 4H). Only
rudiments of AAs without lumen are present in VE-cadherin
morphants (Figure 4G).
Dorsal views of Tg(flk1:EGFP) embryos at 54 hpf show that VE-
cadherin severe morphant embryos present cranial vessels which are
inthecorrectplacebutshow averysmalldiameterand failtoforma
correct lumen (Figure 4J). Furthermore connections between the
CtAs and the BA are defective and CtAs seem to interconnect one
another instead. In addition small sprouting vessels along the length
of few vessels could be observed (asterisks in figure 4J).
VE-cadherin is required for the correct development of
the common cardinal vein and for the closure of the
circulatory loop
We then investigated why injection of high doses of VEcadMO
severely impaired blood circulation. The CCV collects the blood
from the trunk, head and the yolk sac and through the sinus venosus
(SV) is connected to the heart. We therefore analyzed whether
organization and remodeling of this vessel was affected by lack of
VE-cadherin expression. Lateral views of fli1:EGFP control embryos
at 24 hpf show that endothelial cells expand out of the CCVto form
the SV which, within 48 hpf, is fully coated by endothelial cells and
connected to the heart (Figure 5A–C). In VE-cadherin severe
morphants while endothelial cells are still able to sprout from the
CCVat 24 hpf, they areunableto further progress andformthe SV
and fail to establish a correct connection with the heart (Figure 5D–
F). At 48 hpf severe morphants have only few endothelial cells
where the SV should have been formed (arrow in figure 5E). The
absence of this structure impairs the connection of the PCV to the
heart tube and the closure of the first circulatory loop.
A closer analysis shows that endothelial cells in the SV of the
morphants were greatly reduced in number and presented an
altered morphology with strongcell retraction (Figure5J).ZO-1 was
still present in few areas of contact suggesting that other adhesive
proteins at junctions such as claudins, JAMs or N-cadherin may still
promote incomplete cell-cell adhesion (Figure 5J–L).
TUNEL staining of endothelial cells was limited to few cells
(Figure S1) but was quite strong, as expected, in the unperfused
tissues surrounding the ISVs and dorsal longitudinal anastomotic
vessels (DLAV).
In order to confirm the specificity of the vascular phenotype
observed upon injection of VEcadMO, we performed rescue
experiments. In a first attempt we tried to rescue the severe
phenotype using capped mRNA of zebrafish VE-cadherin. Howev-
er, high doses of mRNA (100–400 pg) resulted in high mortality
and abnormalities in the injected embryos. Low doses of VE-
cadherin mRNA (20 pg) that did not cause abnormalities were not
sufficient to rescue the phenotype when coinjected with VEcadMO
(data not shown). We speculate that the overexpression of VE-
cadherin during epiboly and gastrulation may have severe
consequences in the adhesive properties of the cells at these stages
because the morphogenetic movements required to form the
different layers in the early embryo depend on a gradient of cell-
cell adhesiveness [26–31]. This would explain the high mortality
and morphological abnomalities that we observe upon ubiquitous
overexpression of VE-cadherin. In order to achieve an endothelial
specific rescue, we used a fli1:mVE-cadherin construct. The
mCherry tag on the C-terminus of murine VE-cadherin allowed
the detection of mosaic expression in endothelial cells.
Mosaicism was around 9% (Figure S2). Coinjection of the
rescuing construct together with VEcadMO at low dose (MO2,
0.4 ng) resulted in reduction in the percentage of embryos that
presented cranial hemorrhages or severe phenotype to 40%
(n=205) in comparison to 77% of the embryos injected with MO2
alone (n=128) (Figure S2).
The lack of blood flow partially explains the altered
lumen formation in VE-cadherin morphants
Besides SV and CCV, other vessels showed profound alterations
upon injection of high doses of VEcadMO. In addition to the
VE-Cadherin in Zebrafish
PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5772Figure 3. Partial VE-cadherin knockdown affects cranial and trunk vessel integrity. (A–F) Microangiographies performed at 52 hpf. (A–C)
Dorsal views, (D–F) lateral views of the embryos above, anterior to the left. Control embryos (A, D) have a functional and complex cranial vascular
network with lumenized aortic arches (AA) and central arteries (CtA). Microangiograms of embryos injected with low dose (0.8 ng) of VE-cadherin
morpholino that developed hemorrhages (Low VEcadMO) show defects in head perfusion. B, E and C, F correspond to two different embryos with the
sametreatment.Extravasationoftheinjecteddextranisobservedatthesiteofthehemorrhages(asterisk inBandC).Inaddition, onlythefirstaorticarch
(AA1)isfullyformedinthemildmorphantsbut aorticarches3through6donotexhibit circulation(seepanelsE,F).(G–L)Microangiographiesperformed
in Tg(flk1:EGFP) embryos at 54 hpf. Lateral views of trunk vessels are shown. (G, J) EGFP positive vessels, (H, K) microangiograms performed with
rhodamine-dextran, and merge images (I, L). In control embryos (G–I) intersegmental vessels (ISVs), dorsal aorta (DA) and posterior cardinal vein (PCV)
are fully lumenized and the injected dextran remains inside this primary vascular network. In some VE-cadherin mild morphants (Low VEcadMO) these
vessels are apparently normal (J) but leakage is observed in the somites and regions surrounding the ISVs (arrowheads in panels K,L).
doi:10.1371/journal.pone.0005772.g003
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PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e5772Figure 4. Complete VE-cadherin abrogation impairs the formation of a functional vascular network. (A–D) Bright field images of
embryos injected with 16 ng of ctrlMO and VE-cadherin morpholino (High VEcadMO). VE-cadherin severe morphants present a normal morphological
development at 30 hpf (B) but blood circulation is not established (see movies in supplementary material). At 48 hpf lack of circulation persists in this
morphants with severe phenotype, and pericardial edema is observed (arrow in panel D). (E–H) Views of the endocardial and aortic arch region
(highlighted box in C and D) at 52 hpf. Endocardium (En) and aortic arch vessels (AA) are visualized using a flk1:EGFP background (E, G) while
microangiograms show interconnected lumenized vessels filled with rhodamine-dextan (F). VE-cadherin severe morphants form endocardium (En in
panel G) that is not openly connected to the vasculature, neither to the aortic arch 1 (AA1) nor to the CCV, and retains the microinjected dextran in
the heart chambers (HC). Rudiments of AAs without lumen are present in VE-cadherin morphants (G). (I, J) Dorsal views of Tg(flk1:EGFP) embryos at
54 hpf. In embryos injected with high dose of VE-cadherin morpholino (J) cranial vessels are apparently in place but central arteries (CtA) fail to form
the connection to the basilar artery (BA), do not correctly lumenize and small sprouting vessels are present (asterisks).
doi:10.1371/journal.pone.0005772.g004
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presented a reduced or absent lumen at 48 hpf. Confocal analysis
of dorsally oriented embryos allows the visualization of optical
sections of the ISVs that express EGFP under the control of fli1
promoter (Figure 6A,B). The embryos were studied at 48 hpf,
since at this stage ISVs and DLAV are fully lumenized in control
embryos, and confocal images illustrate the absence of lumen in
most of the VE-cadherin morphant ISVs. An important question,
however, is whether these alterations may be a direct effect of VE-
cadherin knockdown or an indirect effect of the lack of circulation.
To clarify this aspect we compared VE-cadherin morphants with
silentheart (sih) morphants that lack blood flow due to complete
impairment of cardiac contractility. We observed that, similarly to
VE-cadherin, sih morphants show strongly reduced lumen in some
portions of ISVs and fairly no lumens in DLAV at 48 hpf
(Figure 6C–E). This suggests that the defect in lumen formation
observed in VE-cadherin morphants might be, at least in part,
explained by lack of flow. In transplantation experiments, donor
cells from fli1:EGFP transgenic embryos were transplanted into
wild type embryos at 4 hpf. At 24 hpf, embryos with GFP positive
ISVs were selected for further analysis (Figure 6F). When
fli1:EGFP wild type embryos were used as donors and AB wild
type as recipients, ISVs did form lumen at 48 hpf and integrated in
host vasculature (Figure 6G). When donor cells, derived from
fli1:EGFP VE-cadherin morphants, were transplanted into wild type
embryos they were able to form thin lumens at 48 hpf (Figure 6H)
but they did not carry blood flow (direct observation). At 72 hpf
the lumen of vessels formed by morphant cells collapsed
(arrowheads in figure 6I) indicating that they failed to correctly
connect to the host vasculature. Overall these data strongly suggest
that VE-cadherin knockdown cells are able to incorporate into the
wild type vasculature but are intrinsically defective and cannot
maintain their adhesive interaction with the surrounding endo-
thelial cells.
Furthermore, the analysis of other regions of the vascular tree
such as the subintestinal vein (SIV) shows that lumen can be
formed also in absence of blood flow as in sih morphants
(Figure 6L) but these vessels, instead, are profoundly altered in VE-
cadherin morphants. Only partially lumenized vessels are present
(Figure 6K), but they do not fully connect to form the SIV.
The vascular phenotype of VE-cadherin morphants is due
to altered vascular connection and fusion
Considering the role of cadherins in cell differentiation [32] we
asked whether VE-cadherin morphants show some defect in vascular
gene expression. The analysis by whole-mount in situ hybridization
shows that VE-cadherin morphants express endothelial markers
without any detectable alteration (Figure S3). The normal
expression of dll4 and ephB4a suggests that arterial-venous
differentiation is correct while expression of gata1 and scl1 in
blood precursors at 20 hpf is consistent with the observation made
in the mouse embryo where hematopoiesis was not affected [9,10].
Many of the vascular defects observed in VE-cadherin morphants
may be explained by the lack of stable connections among
endothelial cells in the different types of vessels. We therefore
investigated this aspect more directly by the analysis of the
dynamics of ISVs and DLAV formation in vivo by performing
time-lapse analysis of their sprouting activity (Movies S7, S8 and
figure 7). As previously reported [33], we observed that in control
embryos, tip endothelial cells form many protruding filopodia
which explore the sourrounding tissue. Once these protrusions
touch other protrusions from a contiguous tip cell, they establish
connections and the sprouting vessels subsequently fuse at the most
dorsal region of the trunk to form DLAV. Interestingly, this
process inhibits formation of new protrusions in the rest of the
vessel. In contrast, embryos injected with high doses of VEcadMO
show a significant delay in the establishment of anastomosis
between contiguous ISVs, and the protruding filopodia touch and
retract several times before establishing a connection. Most
importantly, morphant ISVs maintain significant filopodia activity
even after reciprocal connections are apparently established
(Figure 7 and Movie S8). The sprouting activity is maintained
until 46 hpf (not shown) while in controls it ceases within 36 hpf.
These observations are consistent with the effect of VEcadMO
observed in other types of vessels such as those of the head which
present lack of correct connections and strong sprouting activity
along their length (Figure 4I,J). No significant difference in the
sprouting filopodia of ISVs was observed in sih morphants when
compared to controls (M.M-B., unpublished observations).
Discussion
Intercellular junctions in endothelial cells are important in the
control of permeability to cells and plasma proteins but also for the
correct architecture of the vascular network. The genetic
inactivation in the mouse embryo of members of endothelial AJ
such as VE-cadherin [9,10], b-catenin [34], p120-catenin [35],
VE-PTP [36], and others, results in early fetal lethality. In these
mutants, after the initial patterning and formation of the primitive
vascular plexus, the vessels do not further differentiate and tend to
collapse and regress.
However, the lack of vascular remodeling appears to be a
common feature of the inactivation of several genes expressed in
the vascular system [3]. It is therefore difficult to identify, in the
mouse embryo, the specific activity of VE-cadherin and the precise
step of vascular development in which it is involved.
In this work, using zebrafish embryos, we studied the role of
partial and complete VE-cadherin inactivation on development
and maintenance of the vascular network. This model system is
particularly suited to the study of VE-cadherin function, since the
corresponding zebrafish orthologue maintains, as in the mouse,
endothelial specific expression.
Using two different morpholinos we were able to define several
novel and specific activities of VE-cadherin on vascular develop-
ment. We found that VE-cadherin is not required for a correct
patterning of the vasculature. Trunk and head vessels appear to be
able to branch, and correctly follow elongation pathways.
However, the absence of VE-cadherin inhibits the establishment
Figure 5. Depletion of VE-cadherin affects the formation of the sinus venosus. (A–F) Fluorescence images of fli1:EGFP embryos at the level
of the common cardinal vein (CCV) and sinus venosus (SV). At 24 hpf a number of endothelial cells expand out of the CCV to form the SV both
present in control embryos (A). In VE-cadherin severe morphant embryos (High VEcadMO) a rudiment of SV appears at 24 hpf (D). At 48 hpf the SV is
fully formed in control embryos (B) while in high VEcadMO only few endothelial cells are present (arrow in panel E). Ventral views of fixed embryos
allow the visualization of the endocardium (En) connected to a fully formed SV in control embryos (C). In contrast, high VEcadMO do have a tubular
endocardium (En in panel F) but the SV is not formed. The absence of this structure impairs the connection of the CCV to the heart tube and the
closure of the circulatory loop. (G–L) Immunofluorescence analysis by confocal microscopy of endothelial cells from the SV at 48 hpf. Fli1:EGFP
positive endothelial cells visualized in G and J present intercellular junctions, marked by antibody staining against ZO1 (H, K). The few endothelial
cells present in this SV region in high VEcadMO injected embryos show an aberrant morphology, but form some junctions at the sites of contact.
doi:10.1371/journal.pone.0005772.g005
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PLoS ONE | www.plosone.org 9 June 2009 | Volume 4 | Issue 6 | e5772Figure 6. VE-cadherin expression influences lumen formation. (A–B) Optical cross sections of intersegmental vessels (ISVs) at 48 hpf in
Tg(fli1:EGFP) background acquired at the confocal microscope by positioning the embryo on a dorsal orientation. CtrlMO injected embryos have fully
lumenized ISVs (A) while VE-cadherin severe morphants (High VEcadMO) do not (B). (C–E) Lumenization of ISVs is influenced by blood circulation.
Lateral views of trunk vessels of ctrlMO (C), high VEcadMO (D) and sihMO (E) injected embryos at 48 hpf. At this stage, ISVs and the dorsal longitudinal
anastomotic vessels (DLAV) are fully lumenized in control embryos. In contrast, VE-cadherin and sih morphants present only a very small lumen in
some portions of the ISVs (arrowheads in D and E) and essentially no lumen in DLAV. (F–I) Transplantation experiments. (F) Scheme of the
experimental procedure. Donor cells from fli1:EGFP embryos were transplanted into AB wild type embryos at 4 hpf and, after development, embryos
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PLoS ONE | www.plosone.org 10 June 2009 | Volume 4 | Issue 6 | e5772of successful vessel contacts and fusion which are necessary steps
for lumen formation. Several vessels lack connection with the rest
of the vasculature and present reduced lumen and signs of initial
regression. At high VEcadMO concentrations CCV cannot
connect with the endocardium leaving the heart separated from
the rest of the circulatory system.
The lack of blood flow contributes but does not fully explain the
altered vascular lumenization in VE-cadherin morphants as
suggested by comparison with sih phenotype. While ISVs lacked
lumen in both types of morphants, SIV in sih morphants show the
presence of a fully connected lumen which was instead strongly
reduced or absent in VE-cadherin morphants. These data are
consistent with the observations reported in VE- cadherin null
mouse embryos [9] where, in large vessels, the vascular lumen was
reduced or absent even before the establishment of flow.
Blood flow and shear stress are important factors for vascular
remodeling [37]. Flow is important in the formation of stable
vessels that integrate in a functional network [16,33] and seems to
be required in certain vessels (ISVs) for lumen opening. From the
data presented here we propose that the role of VE-cadherin in
lumen formation may be mediated, directly, by flow-independent
induction of cell polarization and, indirectly, by promoting a
correct connection between the sprouting vessels which is required
for establishment of flow and final reshaping of the lumen.
During vascular development the first vessels which form in the
embryo arise through vasculogenesis. This process involves
endothelial cell differentiation, migration and assembly in tubular
structures. After establishment of the axial blood vessels, smaller
vessels such as the ISVs form through sprouting from the existing
large vessels [16,38]. This process has been studied in detail and
includes endothelial cell migration towards the concentration
gradient of growth factors such as vascular endothelial growth
factor [39]. Migration is directed by ‘‘leader’’ endothelial cells that,
similarly to branching morphogenesis in other tissues, direct the
movement of the cells of the stalk. The leader endothelial cells
form many filopodia at the leading edge which explore the
sourrounding environment [38,40]. When the leader cells
encounter other sprouting vessels they fuse and form a
communicating lumen. Upon fusion, the number of protruding
filopodia rapidly decreases and the vessels form an interconnected
vasculature (see figure 7C).
While the molecular pathways which regulate vascular
sprouting and patterning have been described to a relatively large
extent, very little is known about the molecules implicated in
vascular fusion and lumen formation [38]. The present work
shows for the first time that VE-cadherin plays an important role
in these developmental steps. Most of the vascular defects observed
in VE-cadherin morphants may be explained by the lack of strong
intercellular contacts. When VE-cadherin is reduced or absent,
contacts among vessels are weak and vessel fusion is delayed or
absent (Movies S7, S8 and figure 7). In few regions such as the
head vasculature or ISVs after the small vessels come in contact
they maintain sprouting filopodia (figure 4J and 7B) strongly
suggesting that the interconnection is incomplete and that the
signals which follow vascular fusion are insufficient to abrogate
sprouting. In other regions like the CCV and SV, the connection is
unsuccessful and the vessels detach and eventually regress
(Figures 5E–F).
In the isolated and cultured mouse allantois, in absence of VE-
cadherin, the vessels form a primitive vascular network but they
fail to organize stable connections, the vascular rudiments regress
and the network collapses [41]. This occurs in the absence of flow
and supports the concept that VE-cadherin plays an important
role in the early organization of vascular like structures also in the
absence of mechanical forces.
The abrogation of VE-cadherin in the mouse embryo leads to
endothelial cell apoptosis in a report [9] but not in another [10]. In
the present work we show that apoptosis was very limited in
endothelial cells. A conceivable explanation is that apoptosis of
endothelial cells is more apparent when the vascular phenotype is
more severe as in Carmeliet et al [9]. In the fish the vascular
pattern is rather well preserved and the observed phenotype is
mild as compared to VE-cadherin gene inactivation in the mouse
embryo. This likely explains the reduced apoptotic signal in
vascular endothelium.
In summary, the present study introduces novel findings which
clarify to a good extent the mechanism of action of VE-cadherin in
promoting vascular development and which could not be observed
in the mouse in earlier studies.
In general, VE-cadherin is a key protein in promoting early
stages of vascular connection and fusion. This functional aspect of
the protein fits with our knowledge on its mechanism of action in
in vitro cell culture systems. Several published reports point to a role
of VE-cadherin in transferring signals which promote junctional
integrity and vascular stability [1]. VE-cadherin engagement
inhibits endothelial cell growth, apoptosis and motility and
upregulates a set of genes such as claudin-5 which contributes to
tight junction organization [32]. We report here for the first time
that VE-cadherin engagement may exert a negative feedback
mechanism in reducing formation of sprouting filopodia. We still
do not know the exact mechanism which regulates this inhibitory
process but a recent report [42] shows that small GTPases, which
are regulated by VE-cadherin, play a role through reshaping of the
cell cytoskeleton.
Another novel observation resulting from the present work is
that also a partial reduction in VE-cadherin expression may induce
important defects in vascular integrity such as cranial hemorrhages
and increase in vessel permeability. These defects were not
observed in heterozygous mice where VE-cadherin expression was
reduced by 50% [9,10]. We cannot exclude, however, that stress
conditions such as alterations in blood flow or the combined
reduction of other related junctional proteins may cause
hemorrhages also in heterozygous mice. It has recently been
found in zebrafish that individual knockdown of genes implicated
in junction stability such as Rap1b, Pak2a, b-Pix or ccm1/krit cause
hemorrhagic phenotypes [43–45]. Strikingly, the combined
knockdown of these genes synergizes and results in higher
incidence of intracranial hemorrhages [45]. Importantly, all these
genes are directly or indirectly associated to VE-cadherin and
likely play a role in AJ stabilization. Thus, also partial alterations in
expression or function of endothelial AJ proteins may result in high
frequency of hemorrhagic events and altered control of perme-
ability as we observed in the present study.
with EGFP positive ISVs were selected for analysis. When wild type embryos were used as donor (G), ISVs did form lumen and were integrated into the
host vasculature at 48 hpf. Morphant donor cells transplanted into wild type embryos form thin lumens at 48 hpf (H) that fail to correctly integrate in
the host vasculature and possibly collapse at 72 hpf (arrowheads in panel I). (J–L) Lumenization of subintestinal vein (SIV) is independent of blood
flow as it occurs in the absence of heart beat in sih morphants at 72 hpf (L) but is dramatically affected by the absence of VE-cadherin. High VEcadMO
SIVs display only partially lumenized regions which are not fully interconnected (asterisks in panel K).
doi:10.1371/journal.pone.0005772.g006
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PLoS ONE | www.plosone.org 12 June 2009 | Volume 4 | Issue 6 | e5772Finally, a new finding reported here is that the common
cardinal vein lacks a correct connection with the endocardium
leaving the heart separated from the rest of the circulatory system.
As far as our knowledge it is the first time that this has been
reported for VE-cadherin. The lack of closure of the circulatory
loop may explain some downstream defects described in this
phenotype such as the lack of a correct lumen formation.
Supporting Information
Figure S1 Endothelial cell death is not increased in VE-cadherin
endothelial cells. (A–D) TUNEL assay of 48 hpf embryos in a
fli1:EGFP background allows the colocalization analysis of
apoptotic cells (in red) and endothelial cells (in green). (A–B)
Confocal images of the trunk region at the level of the urogenital
opening are shown. VE-cadherin severe morphants (B) exhibit
increased apoptosis in the blood island (arrowhead) where the
blood cells and hematopoietic precursors (some of them fli1:EGFP
positive) accumulate in the absence of circulation (arrowhead). In
addition, increase in the number of apoptotic cells is observed in
the tissues surrounding the ISVs and DLAV (arrows). Few vascular
endothelial cells (asterisks) show increase in TUNEL staining. (C–
D) Fluorescence microscopy images of the endothelial cells in the
sinus venosus.
Found at: doi:10.1371/journal.pone.0005772.s001 (0.08 MB
PDF)
Figure S2 Endothelial specific expression of murine VE-
cadherin rescues the phenotype of VE-cadherin morphants. A
plasmidic DNA construct containing murine VE-cadherin cDNA
under the zebrafish fli1 enhancer/promoter was coinjected with
0.4 ng of MO2 in order to rescue the hemorrhagic phenotype
observed in the mild morphants. Three independent experiments
were performed and the phenotype of morphant and rescued
embryos was examined under the microscope at 54 hpf. The
graph in panel A shows the mean percentage of embryos showing
a morphant phenotype when injected with morpholino (VE-
cadMO) or morpholino plus plasmid (VEcadMO+mVEcad
cDNA). The number of embryos analyzed is shown in table I.
(B–D) Confocal images. Percentage of mosacism in 6 pairs of
intersegmental vessels (ISV) located in the area of the trunk shown
in figure B is displayed in table II. Average number of endothelial
cells (EC) in 12 ISV+DLAV per embryo (at 48 hpf, n=12, range
34 to 40) was counted in the Tg(fli1:nEGFP)y7 transgenic line,
which shows EGFP-positive EC nuclei. Average number of EC
expressing the transgenes was counted in AB embryos injected
with a mixture of VEcadMO and cDNAs as indicated in the table.
ECs expressing EGFP were counted in the same reference area at
48 hpf (n=40, range 1 to 10). Percentage of mosaicism indicates
the average proportion of EC cells expressing the transgene in 12
ISV+ DLAV. Figures C and D show mosaic expression of the
EGFP transgene in ECs. Insets show co-expression of EGFP and
murine VEcadherin:mCherry in the same ECs.
Found at: doi:10.1371/journal.pone.0005772.s002 (0.15 MB
PDF)
Figure S3 VE-cadherin knockdown does not affect vascular
gene expression. In situ hybridization with pan-endothelial (A–B),
arterial (C–D), venous markers (E–F) and hematopoietic precursor
markers (G–J). Lateral views of the trunk region of 20 hpf embryos
are shown, except A, B that report 24 hpf. Embryos injected with
high dose (8 ng) of control or VE-cadherin morpholinos (high
VEcadMO) were hybridized with the indicated probes (kdrb, dll4,
ephB4a, gata1, scl1). High VEcadMO injected embryos (B, D, F,
H, J) did not present differences in the expression of these markers
when compared to control injected embryos (A, C, E, G).
Found at: doi:10.1371/journal.pone.0005772.s003 (0.10 MB
PDF)
Movie S1 Normal heart beat and blood circulation in control
embryo at 30 hpf. Lateral view, anterior to the left. The heart
beats regularly, and cranial and trunk circulation is correctly
established
Found at: doi:10.1371/journal.pone.0005772.s004 (1.83 MB
MOV)
Movie S2 Trunk circulation in control embryo at 30 hpf.
Lateral view, anterior to the left. Blood cells flow caudally in the
dorsal aorta (upper vessel) and return back through the posterior
cardinal vein (lower vessel).
Found at: doi:10.1371/journal.pone.0005772.s005 (1.50 MB
MOV)
Movie S3 Heart and blood circulation in mild morphant
embryo at 30 hpf. Lateral view, anterior to the left. The heart
beats regularly and the first circulatory loops in head and trunk are
established. Notice some blood cells that tend to accumulate in the
eye.
Found at: doi:10.1371/journal.pone.0005772.s006 (1.62 MB
MOV)
Movie S4 Trunk circulation in mild morphant embryo at
30 hpf. Lateral view, anterior to the left. Circulation is normally
established but circulating blood cells are reduced in number.
Found at: doi:10.1371/journal.pone.0005772.s007 (1.67 MB
MOV)
Movie S5 Absence of circulation in severe morphant embryo at
30 hpf. Lateral view, anterior to the left. The heart beats regularly
but the circulatory loops are not established. Blood circulation is
absent in the head and trunk.
Found at: doi:10.1371/journal.pone.0005772.s008 (1.88 MB
MOV)
Movie S6 Absence of circulation in the trunk of severe
morphant embryo at 30 hpf. Lateral view, anterior to the left.
Blood cells accumulate in the vessels of the trunk and do not
circulate.
Found at: doi:10.1371/journal.pone.0005772.s009 (1.69 MB
MOV)
Movie S7 ISVs sprouting in control embryos. Time-lapse movie.
Lateral view of the trunk region, anterior to the left. Tg(fli1:EGFP)
line was used. Movie starts at 28 hpf (0:00) and ends at 36 hpf
Figure 7. VE-cadherin is required for correct vascular connection and fusion. Time lapse analyses of ISVs of ctrl and high VEcadMO injected
embryos from 28 to 36 hpf, performed in a Tg(fli1:EGFP) background. Lateral views of the trunk vessels are shown at the indicated time points (see
Movies S7 and S8 for full time lapse). In ctrlMO injected embryos (A), dorsal extensions of ISVs that are about to form the DLAV (arrowheads) get
stabilized soon after making contact with neighbouring vessels. In addition, the filopodial activity decreases once the connections are formed and
stops before lumenization (white arrows). See lumen in ISVs at time point 7:00 (yellow arrows). In contrast, vessels of VE-cadherin severe morphants
(B) show defects in establishing stable connections, as they make contact (arrowheads in B) but detach afterwards (red arrowheads). Moreover, the
filopodial activity persists in ISVs even once they already appear dorsally interconnected (red arrows). (C) Model of the filopodial sprouting behaviour
of control and VE-cadherin severe morphant ISVs.
doi:10.1371/journal.pone.0005772.g007
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PLoS ONE | www.plosone.org 13 June 2009 | Volume 4 | Issue 6 | e5772(8:00). Dorsal extensions of ISVs send out filopodial protusions
that upon contact to neighbouring ISVs remain connected.
Filopodial activity decreases progresively and ceases just before
lumen formation.
Found at: doi:10.1371/journal.pone.0005772.s010 (4.82 MB
MOV)
Movie S8 ISVs sprouting in morphant embryos. Time-lapse
movie. Lateral view, anterior to the left. Tg(fli1:EGFP) line was
used. Movie starts at 28 hpf (0:00) and ends at 36 hpf (8:00). ISVs
present a large number of branches and filopodial protusions that
make contact with a neighbouring sprouting vessel but detach and
retract afterwards. Endothelial cells in morphant ISVs show a
highly motile behaviour and the sprouting filopodial activity
persists after the vessels are apparently connected.
Found at: doi:10.1371/journal.pone.0005772.s011 (4.09 MB
MOV)
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